Physician profile
Daniel Alan Nicholson
NPI 1609025790
$2,799.40
in general payments reported to CMS, 2019-2025
32 companies · $845 in 2025
The $845 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $718 · 2021: $301 · 2022: $136 · 2023: $158 · 2024: $154 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Orthopedics LLC | $627.73 | 2020-2024 | |
| Miach Orthopaedics, INC. | $251.62 | 2025 | |
| Ermi LLC | $220.13 | 2019-2025 | |
| Stryker Corporation | $141.68 | 2024-2025 | Biofoam, Ortholoc 3di, Gravity Synchfix |
| Orthogenrx INC. | $137.36 | 2019-2020 | |
| Horizon Therapeutics Plc | $135.72 | 2019-2022 | |
| Depuy Synthes Sales INC. | $115.41 | 2019-2025 | Truespan Orthocord, Healix Knotless Peek, Dynacord |
| Bioventus LLC | $98.32 | 2025 | Xcell |
| Osteomed LLC | $93.01 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $92.43 | 2025 | |
| Avanos Medical | $88.72 | 2022-2023 | Trivisc Sodium Hyaluronate |
| Abbott Laboratories | $86.22 | 2019-2024 | Proclaim |
| Ferring Pharmaceuticals INC. | $71.44 | 2019-2024 | Euflexxa |
| Radius Health, INC. | $65.41 | 2021-2022 | |
| Theragen, INC. | $63.75 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $50.96 | 2023-2025 | Q-Fix, Healicoil, Spatial Frame |
| Pacira Therapeutics, INC. | $48.07 | 2019-2021 | |
| Acumed LLC | $47.62 | 2025 | Acumed |
| Moximed, INC | $45.61 | 2025 | Misha Knee System, Small, Left |
| Zimmer Biomet Holdings, INC. | $40.64 | 2019-2021 | |
| Axogen | $35.74 | 2021 | |
| Vericel Corporation | $33.14 | 2021-2025 | Maci |
| Melinta Therapeutics, LLC | $27.53 | 2019 | |
| Next Science LLC | $27.40 | 2020 | |
| Innovation Technologies INC | $24.37 | 2025 | Irrisept |
| Solventum Corporation | $23.83 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Acera Surgical, INC. | $20.34 | 2025 | Restrata Wound Matrix |
| Trevena, INC. | $20.19 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.97 | 2025 | Iovera, Zilretta, Exparel |
| Paratek Pharmaceuticals, INC. | $18.96 | 2022 | |
| Fidia Pharma USA INC. | $14.41 | 2023 | Hymovis, Triluron |
| Integra Lifesciences Corporation | $11.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.